Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

18/8/2025

Annals On Call Podcast

0:00

29:55

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.

Altri episodi di "Annals On Call Podcast"

Palliative Care: A Family Perspective
17/11/2025
19:37
Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.
What You May Have Missed in 2024: Part 3
3/11/2025
15:33
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
Non perdere nemmeno un episodio di “Annals On Call Podcast”. Iscriviti all'app gratuita GetPodcast.
What You May Have Missed in 2024 - Part 2
20/10/2025
13:52
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
High-Concentration Cannabinoids: Are They Safe?
6/10/2025
29:05
Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.
What You May Have Missed in 2024: Part 1
15/9/2025
20:13
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
Fibrillation - When Ablation is the Way to Go
1/9/2025
22:36
Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
18/8/2025
29:55
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide
4/8/2025
21:11
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
Diagnosing Primary Aldosteronism
14/7/2025
23:56
Dr. Centor discusses the diagnosis of primary aldosteronism with Dr. Jordana Cohen.
Virtual Urgent Care: Artificial Intelligence Versus Physicians
30/6/2025
19:07
Dr. Centor discusses artificial intelligence-assisted urgent care with Dr. Zehavi Kugler.

Altri episodi

Accedi a tutto il mondo dei podcast con l’app gratuita GetPodcast.

Iscriviti ai tuoi podcast preferiti, ascolta gli episodi offline e ricevi fantastici consigli.

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

Annals On Call Podcast

Altri episodi di "Annals On Call Podcast"

Palliative Care: A Family Perspective

What You May Have Missed in 2024: Part 3

What You May Have Missed in 2024 - Part 2

High-Concentration Cannabinoids: Are They Safe?

What You May Have Missed in 2024: Part 1

Fibrillation - When Ablation is the Way to Go

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide

Diagnosing Primary Aldosteronism

Virtual Urgent Care: Artificial Intelligence Versus Physicians